Optimer Pharmaceuticals (OPTR): Q1 EPS of -$0.23 may not be comparable to consensus of $-0.40....

|About: Optimer Pharmaceuticals,... (OPTR)|By:, SA News Editor
Optimer Pharmaceuticals (OPTR): Q1 EPS of -$0.23 may not be comparable to consensus of $-0.40. Revenue of $14.4M (-79.2% Y/Y) misses by $14M. (PR)